Discover how semaglutide can help you lose weight, improve your health, and enhance your quality of life
Wegovy is prescribed for adults with: A BMI of 30 or higher (obesity classification) A BMI of 27 or higher with weight-related health conditions (hypertension, type 2 diabetes, heart disease) A history of weight regain after previous weight loss attempts Clinical Effectiveness Studies show Wegovy users lose an average of 15-22% of their body weight over 68 weeks
Evidence from an animal model also shows that AGEs can induce insulin resistance by repressing the skeletal muscle glucose transporter GLUT4 [108]
True fat loss is shaped by behaviour, hormones, metabolism, and mindset
Use it as a post-workout snack: The protein helps with muscle recovery while the carbs help replenish energy stores, making it an ideal combination for supporting your fitness goals and weight management efforts
Others activate AMPK to convert white fat into metabolically active brown fat